Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 1 Sociodemographic and clinical characteristics of patients and controls

From: Natural IgG antibodies to β amyloid are decreased in patients with Parkinson’s disease

 

Healthy Controls

PD

AD

VAD

For trend

p-value

15

15

30

31

 

Age (yy)

69.13 ± 3.55

74.25 ± 2.57

72.83 ± 1.34

75.30 ± 1.74

0.25

Male Sex (n° %)

5 (33.3)

9 (56.3)

12 (40.0)

8 (26.7)

0.31

MMSE score

26.92 ± 1.77

25.75 ± 0.65

20.19 ± 1.45

19.56 ± 0.99*

0.01

Education (yy)

3.73 ± 0.97

4.25 ± 0.30

3.53 ± 0.48

3.50 ± 0.70

0.88

CIRS score

7.07 ± 1.83

1.94 ± 0.88 *

5.67 ± 0.76

7.59 ± 0.86

0.003

Disease diagnosed (mo)

N.A

16 ± 4

30 ± 14

18 ± 11

0.77

  1. PD Parkinson’s Disease, AD Alzheimer Dementia, VAD Vascular Dementia, CIRS Cumulative Illness Rating Scale
  2. *denotes p < 0.05 vs control; N.A not applicable
Back to article page

Immunity & Ageing

ISSN: 1742-4933

Contact us